Intercept`s liver drug gets conditional backing of EMA panel
Drugmaker Intercept Pharmaceuticals Inc’s drug to treat a rare liver condition was conditionally approved an advisory committee to the European Medicines Agency on Friday. More »
Drugmaker Intercept Pharmaceuticals Inc’s drug to treat a rare liver condition was conditionally approved an advisory committee to the European Medicines Agency on Friday. More »